L&S Knock-Out BIO/ DE000LS1X279 /
9/7/2024 1:03:56 PM | Chg.0.00 | Bid1:03:56 PM | Ask1:03:56 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.80EUR | 0.00% | 0.80 Bid Size: - |
0.84 Ask Size: - |
BB BIOTECH AG | 31.5604 EUR | 12/31/2078 | Call |
GlobeNewswire
3/28
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...
GlobeNewswire
6/17/2021
Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...
GlobeNewswire
12/16/2019
Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...
GlobeNewswire
10/19/2018
Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...
GlobeNewswire
1/2/2018
Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
GlobeNewswire
10/19/2017
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
GlobeNewswire
12/2/2016
Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...
GlobeNewswire
7/29/2016
Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire
7/15/2016
BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire
7/14/2016
BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...